tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

KYTX Stock Latest News

Kyverna Therapeutics price target lowered to $4 from $6 at H.C. Wainwright
The FlyKyverna Therapeutics price target lowered to $4 from $6 at H.C. Wainwright
1M ago
KYTX
Kyverna Therapeutics price target lowered to $20 from $40 at Morgan Stanley
PremiumThe Fly
Kyverna Therapeutics price target lowered to $20 from $40 at Morgan Stanley
1M ago
KYTX
PremiumRatings
Kyverna Therapeutics: Strategic Advancements and Robust Financial Health Underpin Buy Rating
1M ago
KYTX
Kyverna Therapeutics price target lowered to $12 from $13 at UBS
PremiumThe Fly
Kyverna Therapeutics price target lowered to $12 from $13 at UBS
1M ago
KYTX
PremiumCompany Announcements
Kyverna Therapeutics Advances CAR T-Cell Therapy Trials
1M ago
KYTX
Kyverna Therapeutics files $250M mixed securities shelf
PremiumThe FlyKyverna Therapeutics files $250M mixed securities shelf
1M ago
KYTX
Kyverna Therapeutics sees cash and securities sufficient into 2027
Premium
The Fly
Kyverna Therapeutics sees cash and securities sufficient into 2027
1M ago
KYTX
Kyverna appoints Naji Gehchan as Chief Medical and Development Officer
Premium
The Fly
Kyverna appoints Naji Gehchan as Chief Medical and Development Officer
4M ago
LLY
KYTX
PremiumCompany Announcements
Kyverna Therapeutics Sets 2025 Strategic Priorities for Growth
4M ago
8K
KYTX
Kyverna Therapeutics announces senior leadership appointments
PremiumThe Fly
Kyverna Therapeutics announces senior leadership appointments
5M ago
KYTX
PremiumClass Action
Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky LLP
5M ago
KYTX
JPMorgan healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
JPMorgan healthcare analysts hold an analyst/industry conference call
5M ago
ALLO
IGMS
Kyverna shares remain ‘significantly under-valued,’ says JPMorgan
PremiumThe FlyKyverna shares remain ‘significantly under-valued,’ says JPMorgan
5M ago
KYTX
Premium
Company Announcements
Kyverna CMO Resignation Highlights Leadership Transition Impact
5M ago
8K
KYTX
Kyverna Therapeutics price target lowered to $6 from $7 at H.C. Wainwright
Premium
The Fly
Kyverna Therapeutics price target lowered to $6 from $7 at H.C. Wainwright
6M ago
KYTX
Kyverna Therapeutics price target lowered to $24 from $44 at Wells Fargo
PremiumThe Fly
Kyverna Therapeutics price target lowered to $24 from $44 at Wells Fargo
6M ago
KYTX
PremiumCompany Announcements
Kyverna Therapeutics Reports Q3 Loss Amid Rising R&D Costs
6M ago
KYTX
Kyverna Therapeutics anounces patient data on KYV-101
PremiumThe Fly
Kyverna Therapeutics anounces patient data on KYV-101
6M ago
KYTX
PremiumCompany Announcements
Kyverna Therapeutics Advances in Cell Therapy Leadership
6M ago
8K
KYTX
Kyverna Therapeutics reports Q3 EPS (80c), consensus (79c)
PremiumThe FlyKyverna Therapeutics reports Q3 EPS (80c), consensus (79c)
6M ago
KYTX
Premium
Company Announcements
Kyverna Therapeutics Strengthens Board with New Appointment
7M ago
8K
KYTX
Kyverna Therapeutics initiated with a Buy at UBS
Premium
The Fly
Kyverna Therapeutics initiated with a Buy at UBS
7M ago
KYTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >